Evidence map›Paper›PMID 41350865›Full record

ArticleMolecular cancer2025

CircRNF10 sequestrates β-catenin by a dual regulatory circuit of direct degradation and a miR-1275/DKK3-mediated inhibition in driver gene- negative lung adenocarcinoma.

Xiaohua Situ, Xinwei Wang, Xiting Liao, Xiaoxuan Zhang, Sicheng Chen, Fei Fang, Lihong Wei, Peng Wu, Zhiyu Liu, Honglei Chen and 3 more

Abstract read
In one paragraph

Article in Molecular cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Xiaohua Situ *Molecular Diagnosis and Gene Test Centre, First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, Guangdong, China.
Xinwei Wang *Molecular Diagnosis and Gene Test Centre, First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, Guangdong, China.
Xiting Liao *Molecular Diagnosis and Gene Test Centre, First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, Guangdong, China.
Xiaoxuan ZhangMolecular Diagnosis and Gene Test Centre, First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, Guangdong, China.
Sicheng ChenMolecular Diagnosis and Gene Test Centre, First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, Guangdong, China.
Fei FangMolecular Diagnosis and Gene Test Centre, First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, Guangdong, China.
Lihong WeiMolecular Diagnosis and Gene Test Centre, First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, Guangdong, China.
Peng WuMolecular Diagnosis and Gene Test Centre, First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, Guangdong, China.
Zhiyu LiuSouthern Medical University, Guangzhou, Guangdong, China.
Honglei ChenDepartment of Pathology, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China.
Kejing TangDepartment of Pulmonary and Critical Care Medicine, The First Affiliated Hospital, Sun Yat-Sen University, No. 58. Zhongshan Second Road, Guangzhou, 510080, Guangdong, China. tangkj@mail.sysu.edu.cn.
Lihong BaiDepartment of Pulmonary and Critical Care Medicine, The First Affiliated Hospital, Sun Yat-Sen University, No. 58. Zhongshan Second Road, Guangzhou, 510080, Guangdong, China. bailh5@mail.sysu.edu.cn.
Zunfu KeMolecular Diagnosis and Gene Test Centre, First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, Guangdong, China. kezunfu@mail.sysu.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCircular RNAs (circRNAs) exert critical regulatory functions in tumor biology by modulating pathways associated with oncogenesis or tumor suppression. Despite substantial progress in elucidating their roles in several malignancies, the contribution of circRNAs to the pathogenesis of driver gene-negative lung adenocarcinoma (LUAD), a molecular subtype lacking actionable genetic alterations and exhibiting limited response to existing targeted or immunotherapeutic strategies, remains poorly defined.

methodsThe expression of circRNF10 in driver gene-negative LUAD was analyzed using circRNA microarray analysis followed by RT-qPCR validation. A series of functional assays were performed both in vitro and in vivo to evaluate the effects of circRNF10 on tumor cell behavior, including proliferation (EdU incorporation), migration (wound healing), and invasion (transwell assays), as well as tumor growth in a murine model. To elucidate the underlying molecular mechanism, we employed a combination of computational and experimental approaches, including AlphaFold3-based structural prediction, in vitro transcription, biotin-labeled RNA pulldown, RNA immunoprecipitation (RIP), and dual-luciferase reporter assays.

resultsIn this study, we identified a previously uncharacterized circular RNA, circRNF10, which is markedly downregulated in driver gene-negative lung adenocarcinoma (LUAD) and positively associated with favorable clinical outcomes. Functional analyses revealed that circRNF10 overexpression suppresses LUAD cell proliferation, migration, and invasion in vitro and in vivo, primarily through inhibition of the Wnt/β-catenin signaling pathway. Mechanistically, circRNF10 directly interacts with β-catenin via its cyclization site, thereby promoting β-catenin degradation. Moreover, circRNF10 functions as a competing endogenous RNA by sequestering miR-1275, thereby alleviating the miR-1275-mediated suppression of DKK3, a potent inhibitor of the Wnt pathway. Our findings further confirm that circRNF10 promotes β-catenin degradation through direct interaction and modulation of the miR-1275/DKK3 signaling cascade.

conclusionsCollectively, our findings highlight circRNF10 as a tumor suppressor in driver gene-negative LUAD and suggest that restoring circRNF10 expression represents a promising therapeutic approach for this refractory subtype.

Indexed as

Adaptor Proteins, Signal TransducingAdenocarcinoma of Lungbeta CateninLung NeoplasmsMicroRNAsRNA, CircularAnimalsCell Line, TumorCell MovementCell ProliferationDisease Models, AnimalGene Expression Regulation, NeoplasticHumansMiceWnt Signaling PathwayAdaptor Proteins, Signal Transducingbeta CateninCTNNB1 protein, humanDKK3 protein, humanMicroRNAsRNA, CircularCircRNF10Circular RNADickkopf-related protein 3 (DKK3)LUADMiRNAWnt/β-catenin

Identifiers

PMID41350865
PMCPMC12797959

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.